Microemulsion-based topical hydrogels containing lemongrass leaf essential oil (Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract (Mangifera indica Linn) for acne treatment: Preparation and in-vitro evaluations
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312841 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ngoc Nha Thao Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam. Hauptthemen laut MEDLINE: Hydrogels, Emulsions, Acne Vulgaris, Mangifera. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Current treatments for severe acne include combinations of synthetic anti-inflammatory and antibacterial drugs, which possess numerous side effects. Therefore, this study developed microemulsion-based hydrogel containing lemongrass leaf essential oil ( Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract ( Mangifera indica Linn) as a potential natural therapy for inflammatory acne. To this end, the microemulsions were first prepared using pseudo-ternary phase diagrams with soybean oil and coconut oil, cremophor RH40, and PEG 400. The optimal formula could load 1% lemongrass oil and 10% mango extract, possessed a spherical droplet size of ~18.98 nm, a zeta potential of -5.56 mV, and a thermodynamic stability. Secondly, the microemulsion-based hydrogel was developed by simple mixing the optimal microemulsion in carbopol-940 hydrogel (3.5% w/w). The product showed a viscosity of ~3728 cPs, a pH of 5.4-6.2, a spreadability of ~24 cm, an in-vitro Franz-cell cumulative release rate of ~80% for polyphenol content and ~60% for citral within 12 h, and a good physicochemical stability of > 3 months. Thirdly, the skin compatibility/irritability of the microemulsion-based hydrogel was determined by the HET-CAM assay, which showed non-irritation level. Finally, the anti-inflammatory activities of the hydrogel, using heat-induced BSA denaturation assay and LPS-stimulated RAW 264.7 NO inhibition assay, was 4-times higher than that of the reference drug Klenzit-C ® (adapalene and clindamycin gel). Moreover, the hydrogel possessed strong anti-biofilm activity in Cutibacterium acnes , comparable with Klenzit-C ® . Conclusively, the microemulsion-based hydrogel containing lemongrass oil and mango seed extract demonstrated much potentials to be a promising natural drug for acne treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.
- DHG Pharmaceutical Joint-Stock Company, Can Tho, Vietnam.
- Hycha Vietnam Limited Company, Can Tho, Vietnam.
- Department of Health Sciences, College of Natural Sciences, Can Tho University, Can Tho, Vietnam.
ORCID-Profile: Dang Tuyet Minh Than, Duy Toan Pham
Zitieren
APA
Nguyen, N. N. T., Nguyen, T. T. D., Vo, D. L., Than, D. T. M., Tien, G. P., & Pham, D. T. (2024). Microemulsion-based topical hydrogels containing lemongrass leaf essential oil (Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract (Mangifera indica Linn) for acne treatment: Preparation and in-vitro evaluations. PLOS ONE. https://doi.org/10.1371/journal.pone.0312841
Vancouver
Nguyen NNT, Nguyen TTD, Vo DL, Than DTM, Tien GP, Pham DT. Microemulsion-based topical hydrogels containing lemongrass leaf essential oil (Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract (Mangifera indica Linn) for acne treatment: Preparation and in-vitro evaluations. PLOS ONE. 2024. doi:10.1371/journal.pone.0312841
BibTeX
@article{Nguyen2024,
author = {Nguyen, Ngoc Nha Thao and Nguyen, Thi Trang Dai and Vo, Duc Linh and Than, Dang Tuyet Minh and Tien, Gia Phuoc and Pham, Duy Toan},
title = {Microemulsion-based topical hydrogels containing lemongrass leaf essential oil (Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract (Mangifera indica Linn) for acne treatment: Preparation and in-vitro evaluations},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312841}
}
EUVIMED